Technology Licensing

For inquires regarding VelociGene, VelociMouse, or VelocImmune licensing or partnership opportunities, please contact us at business.development@regeneron.com.

News & Publications genome
September 7, 2006
VelociGene technology selected for the NIH Knockout Mouse Project (KOMP)

More News | Publications
KOMP KOMP
Regeneron Will Use its VelociGene® Technology to Target Genes, Providing New Models of Human Disease.

Data Access
Industry-Leading Timelines timeline
Fastest from concept to Knockout mice without sacrificing precision and complexity.

Learn about our services
The Power of Gene Reporting lacZ Gallery
VelociGene allows scientists to rapidly identify the physical and biological effects of deleting or over-expressing the target gene. View Slideshow